CD123 x CD3 dual affinity re-targeting (DART®) protein

CD123 x CD3 dual affinity re-targeting (DART®) protein
Trade Name
Orphan Indication Acute myeloid leukemia
USA Market Approval USA
USA Designation Date 2016-12-22 00:00:00
Sponsor MacroGenics, Inc.;9704 Medical Center Drive;Rockville, Maryland, 20850
Related Access Program
Children’s Hospital Los Angeles – Acute myeloid leukemia Jazz Pharmaceuticals – Secondary AML Celator Pharmaceuticals – Secondary AML University of California, San Francisco – Acute myeloid leukemia Emory University – Acute myeloid leukemia